[1]
“Efficacy and safety of narrowband ultraviolet B therapy in moderate to severe atopic dermatitis”, J Pak Assoc Dermatol, vol. 21, no. 2, pp. 106–108, Dec. 2016, doi: 10.66344/jpad.v21i2.451.